Cowen & Co
http://www.cowen.com/default.htmlCowen and Company offers investment banking services, including equity research, equity and convertible debt financings, mergers and acquisitions advisory services, and restricted security sales.
-
Stemline Therapeutics Closes $92 Million Public Offering of Common Stock
-
Stemline Therapeutics (STML) Prices 8.89M Share Upsized Common Offering at $9/Sh
-
Stemline Therapeutics Announces Upsizing and Pricing of $80 Million Public Offering of Common Stock
-
Stemline Therapeutics to Present at Upcoming Investor Conferences
-
Stemline Therapeutics Closes $59.6 Million Public Offering of Common Stock
-
Stemline Therapeutics (STML) Prices 3.7M Share Offering at $14/Sh
-
Stemline Therapeutics Prices $51.8 Million Public Offering of Common Stock
-
Stemline Therapeutics (STML) Plans 3.7M Common Stock Offering
-
Stemline Therapeutics Announces Proposed Public Offering of Common Stock
-
Stemline Therapeutics to Present at the Cowen and Company 37th Annual Health Care Conference
-
UPDATE: Stemline Therapeutics (STML) Investors Are Over-Reacting, Says Cowen
-
Stemline Therapeutics (STML) Prices 4.5M Shares at $10
-
Stemline Therapeutics Prices $45 Million Public Offering of Common Stock
-
Stemline Therapeutics to Present at the Cowen and Company 36th Annual Health Care Conference
-
Updated: Cowen Starts Stemline Therapeutics (STML) at Outperform
-
Stemline Therapeutics (STML) Prices 3.8M Common Offering at $15.75/Share
-
Stemline Therapeutics Prices $59.85 Million Public Offering of Common Stock
-
Stemline Therapeutics (STML) Plans Common Stock Offering
-
Stemline Therapeutics Announces Proposed Public Offering of Common Stock

